Abstract
Purpose of review
The purpose of this review was to explore the different sleep disorders associated with MSA, their mechanisms, and their treatments.
Recent findings
Stridor is a red flag for the diagnosis of MSA. Recent findings show that its presence in early stage of the disease is associated with a reduction in life expectancy. Its management should be fast and adapted. Its treatment with continuous positive airway pressure or tracheostomy is efficacious.
Summary
Sleep disorders in MSA are frequent and severe combining insomnia, daytime sleepiness, restless legs syndrome (RLS), REM sleep behavior disorder (RBD), and sleep disordered breathing (SDB). Sleep recordings confirm these disorders. Mechanisms involved in these disorders are complex associating (a) lesions of the pathways regulating sleep and wake or mood but also controlling movement, (b) iatrogenic effects of the treatments, and (3) consequences of the motor or dysautonomic symptoms. RBD prevalence is very high at the beginning of the motor symptoms but then seems to disappear.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Gilman S, Wenning G, Low P, Brooks D, Mathias C, Trojanowski J, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670–6.
Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med . 2015;372(3):249–263.
Schrag A, Geser F, Stampfer-Kountchev M, Seppi K, Sawires M, Köllensperger M, et al. Health-related quality of life in multiple system atrophy. Mov Disord. 2006;21(6):809–15.
Ben-Shlomo Y, Wenning GK, Tison F, Quinn NP. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology. 1997;48(2):384–93.
Schrag A, Wenning GK, Quinn N, Ben-Shlomo Y. Survival in multiple system atrophy. Mov Disord. 2008;23(2):294–6.
Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, et al. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol. 2013;12(3):264–74.
Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, et al. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol. 2015;14(7):710–9.
•• Giannini G, Calandra-Buonaura G, Mastrolilli F, Righini M, Bacchi-Reggiani ML, Cecere A, et al. Early stridor onset and stridor treatment predict survival in 136 patients with MSA. Neurology. 2016, 87;(13):1375–83. The largest study on stridor and its treatments in MSA.
Iranzo A, Santamaria J, Tolosa E, Vilaseca I, Valldeoriola F, Martí MJ, et al. Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology. 2004;63(5):930–2.
Ghorayeb I, Bioulac B, Tison F. Sleep disorders in multiple system atrophy. J Neural Transm. 2005;112(12):1669–75.
Cochen De Cock V, Debs R, Oudiette D, Leu S, Radji F, Tiberge M, et al. The improvement of movement and speech during rapid eye movement sleep behaviour disorder in multiple system atrophy. Brain. 2011;134(3):856–62.
Guo XY, Cao B, Lei F, Huang L, Chen K, Song W, et al. Clinical and polysomnographic features of patients with multiple system atrophy in Southwest China. Sleep Breath. 2013;17(4):1301–7.
Wetter TC, Collado-Seidel V, Pollmächer T, Yassouridis A, Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep 2000;23(3):361–367.
Cochen De Cock V. Sleep disorders in Parkinson’s-plus syndromes. In: Overeem S, Reading P, editors. Sleep disorders in neurology: a practical approach. Wiley-Blac. Oxford; 2010. p. 115–23.
Ozawa T, Tanaka H, Nakano R, Sato M, Inuzuka T, Soma Y, et al. Nocturnal decrease in vasopressin secretion into plasma in patients with multiple system atrophy. J Neurol Neurosurg Psychiatry. 1999;67(4):542–5.
Sakakibara R, Matsuda S, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T. The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res. 2003;13(2):106–8.
Ferini-Strambi L, Marelli S. Sleep dysfunction in multiple system atrophy. Curr Treat Options Neurol. 2012;14(5):464–73.
Moreno-López C, Santamaría J, Salamero M, Del Sorbo F, Albanese A, Pellecchia MT, et al. Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study). Arch Neurol. 2011;68(2):223–30.
Shimohata T, Nakayama H, Tomita M, Ozawa T, Nishizawa M. Daytime sleepiness in Japanese patients with multiple system atrophy: prevalence and determinants. BMC Neurol. 2012;12:130.
Bhalsing K, Suresh K, Muthane UB, Pal PK. Prevalence and profile of restless legs syndrome in Parkinson’s disease and other neurodegenerative disorders: a case-control study. Parkinsonism Relat Disord. 2013;19(4):426–30.
Ghorayeb I, Dupouy S, Tison F, Meissner WG. Restless legs syndrome in multiple system atrophy. J Neural Transm. 2014;121(12):1523–7.
Gama RL, Távora DG, Bomfim RC, Silva CE, de Bruin VM, de Bruin PFC. Sleep disturbances and brain MRI morphometry in Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy—a comparative study. Parkinsonism Relat Disord. 2010;16(4):275–9.
Muntean M-L, Sixel-Döring F, Trenkwalder C. No difference in sleep and RBD between different types of patients with multiple system atrophy: a pilot video-polysomnographical study. Sleep Disord. 2013;2013:258390.
Ferini-Strambi L. RLS-like symptoms: differential diagnosis by history and clinical assessment. Sleep Med. 2007;8(SUPPL. 2):S3–6.
Rijsman RM, Schoolderman LF, Rundervoort RS, Louter M. Restless legs syndrome in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20:S5–9.
De Cock VC, Bayard S, Yu H, Grini M, Carlander B, Postuma R, et al. Suggested immobilization test for diagnosis of restless legs syndrome in Parkinson’s disease. Mov Disord. 2012;27(6):743–9.
Ghorayeb I, Dupouy S, Tison F, Meissner WG. Restless legs syndrome in multiple system atrophy. J Neural Transm. 2014;121(12):1523–7.
Earley CJ, Connor J, Garcia-Borreguero D, Jenner P, Winkelman J, Zee PC, et al. Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis-Ekbom disease). Sleep Med. 2014;15:1288–301.
Connor JR, Wang XS, Allen RP, Beard JL, Wiesinger JA, Felt BT, et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain. 2009;132(9):2403–12.
Pittock SJ, Parrett T, Adler CH, Parisi JE, Dickson DW, Ahlskog JE. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov Disord. 2004;19(6):695–9.
• Videnovic A. Management of sleep disorders in Parkinson’s disease and multiple system atrophy. Mov Disord. 2017;32(5):659–68. Review on the management of parkinsonian syndroms.
Vetrugno R, Provini F, Cortelli P, Plazzi G, Lotti EM, Pierangeli G, et al. Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study. Sleep Med. 2004;5(1):21–30.
Muntean ML, Trenkwalder CWalters AS, Mollenhauer B, Sixel-Döring F. Are REM sleep behavioral events dream enactments? Sleep Med. 2015;16:S13.
Cochen De Cock V, Debs R, Oudiette D, Leu-Semenescu S, Radji F, Tiberge M, et al. The improvement of movement and speech during rapid eye movement sleep behaviour disorder in multiple system atrophy. Brain. 2011;134:856–62.
Iranzo A, Santamaría J, Rye DB, Valldeoriola F, Martí MJ, Muñoz E, et al. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology. 2005;65(2 SUPPL. 1):247–52.
Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology. 1992;42(7):1371–4.
Schenck CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep. 2002;25(2):120–38.
Comella CL, Nardine TM, Diederich NJ, Stebbins GT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson’s disease. Neurology. 1998;51:526–9.
Iranzo A, Santamaria J, Tolosa E. Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. The Lancet Neurology. 2016;15:405–19.
• Palma J-A, Fernandez-Cordon C, Coon EA, Low PA, Miglis MG, Jaradeh S, et al. Prevalence of REM sleep behavior disorder in multiple system atrophy: a multicenter study and meta-analysis. Clin Auton Res. 2015;25:69–75. Meta-analysis on RBD in MSA.
Nomura T, Inoue Y, Högl B, Uemura Y, Yasui K, Sasai T, et al. Comparison of the clinical features of rapid eye movement sleep behavior disorder in patients with Parkinson’s disease and multiple system atrophy. Psychiatry Clin Neurosci. 2011;65(3):264–71.
Benarroch EE. Brainstem in multiple system atrophy: Clinicopathological correlations. Cell Mol Neurobiol. 2003;23:519–26.
Vetrugno R, Alessandria M, D’Angelo R, Plazzi G, Provini F, Cortelli P, et al. Status dissociatus evolving from REM sleep behaviour disorder in multiple system atrophy. Sleep Med. 2009;10(2):247–52.
De Cock VC, Vidailhet M, Leu S, Texeira A, Apartis E, Elbaz A, et al. Restoration of normal motor control in Parkinson’s disease during REM sleep. Brain. 2007;130(2):450–6.
Mayer G, Bitterlich M, Kuwert T, Ritt P, Stefan H. Ictal SPECT in patients with rapid eye movement sleep behaviour disorder. Brain. 2015;138(5):1263–70.
Gagnon J-F, Postuma RB, Montplaisir J. Update on the pharmacology of REM sleep behavior disorder. Neurology. 2006;67:742–7.
Kunz D, Bes F. Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations. Neuropsychobiology. 1997;36(4):211–4.
Shimohata T, Tomita M, Nakayama H, Aizawa N, Ozawa T, Nishizawa M. Floppy epiglottis as a contraindication of cpap in patients with multiple system atrophy. Neurology. 2011;76(21):1841–2.
• Flabeau O, Ghorayeb I, Perez P, Maillard A, Taillard J, Philip P, et al. Impact of sleep apnea syndrome on survival in patients with multiple system atrophy. Park Relat Disord. 2017;35:92–5. Study on obstructive sleep apnea in MSA.
• Ohshima Y, Nakayama H, Matsuyama N, Hokari S, Sakagami T, Sato O, et al. Natural course and potential prognostic factors for sleep-disordered breathing in multiple system atrophy. Sleep Med. 2017;34:13–7. Study on natural course of sleep disordered breathing in MSA.
Ghorayeb I, Yekhlef F, Chrysostome V, Balestre E, Bioulac B, Tison F. Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry. 2002;72(6):798–800.
• Ozawa T, Sekiya K, Aizawa N, Terajima K, Nishizawa M. Laryngeal stridor in multiple system atrophy: Clinicopathological features and causal hypotheses. J Neurol Sci. 2016;361:243–9. Study on pathophysiology of stridor.
Osaki Y, Ben-Shlomo Y, Lees AJ, Wenning GK, Quinn NP. A validation exercise on the new consensus criteria for multiple system atrophy. Mov Disord. 2009;24(15):2272–6.
Isozaki E, Naito A, Horiguchi S, Kawamura R, Hayashida T, Tanabe H. Early diagnosis and stage classification of vocal cord abductor paralysis in patients with multiple system atrophy. J Neurol Neurosurg Psychiatry. 1996;60(4):399–402.
Vetrugno R, Liguori R, Cortelli P, Plazzi G, Vicini C, Campanini A, et al. Sleep-related stridor due to dystonic vocal cord motion and neurogenic tachypnea/tachycardia in multiple system atrophy. Mov Disord. 2007;22(5):673–8.
Iranzo a SJ, Tolosa E. Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. Lancet. 2000;356(9238):1329–30.
Yamaguchi M, Arai K, Asahina M, Hattori T. Laryngeal stridor in multiple system atrophy. Eur Neurol. 2003;49(3):154–9.
Jin K, Okabe S, Chida K, Abe N, Kimpara T, Ohnuma A, et al. Tracheostomy can fatally exacerbate sleep-disordered breathing in multiple system atrophy. Neurology. 2007;68(19):1618–21.
Silber MH, Levine S. Stridor and death in multiple system atrophy. Mov Disord. 2000;15(4):699–704.
Tada M, Onodera O, Tada M, Ozawa T, Piao Y-S, Kakita A, et al. Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy. Arch Neurol. 2007;64(2):256–60.
Coon EA, Sletten DM, Suarez MD, Mandrekar JN, Ahlskog JE, Bower JH, et al. Clinical features and autonomic testing predict survival in multiple system atrophy. Brain. 2015;138(Pt 12):3623–31.
Tada M, Kakita A, Toyoshima Y, Onodera O, Ozawa T, Morita T, et al. Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death. Brain. 2009;132(7):1810–9.
Iranzo A. Sleep and breathing in multiple system atrophy. Curr Treat Options Neurol. 2007;9(5):347–53.
Aldara Garcia-Sanchez MBBS, Isabel Fernandez-Navarro MD, Francisco Garcia-Rio M. Central apneas and REM sleep behavior disorder as an initial presentation of multiple system atrophy. J Clin Sleep Med. 2016;12(2):267–70.
Benarroch EE. Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy. Mov Disord. 2007;22:155–61.
Hamada S, Takahashi R, Mishima T, Chin K. Use of a new generation of adaptive servo ventilation for sleep-disordered breathing in patients with multiple system atrophy. BMJ Case Rep. 2015;6
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The author declares that she has no conflicts of interest.
Human and Animal Rights and Informed Consent
All reported studies with human subjects performed by the authors have been previously published and complied with all applicable ethical standards.
Additional information
This article is part of the Topical Collection on Sleep Disorders
Rights and permissions
About this article
Cite this article
Cochen De Cock, V. Sleep Abnormalities in MultipleSystem Atrophy. Curr Treat Options Neurol 20, 16 (2018). https://doi.org/10.1007/s11940-018-0503-8
Published:
DOI: https://doi.org/10.1007/s11940-018-0503-8